$ORGO
Organogenesis Holdings Inc.

2020 Q2 Form 10-Q Financial Statement

#000119312520139057 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $68.96M $61.73M $57.12M
YoY Change 6.18% 8.07% 60.78%
Cost Of Revenue $20.04M $18.79M $16.98M
YoY Change 3.06% 10.68% 16.93%
Gross Profit $48.92M $42.94M $40.14M
YoY Change 7.51% 6.97% 91.08%
Gross Profit Margin 70.94% 69.56% 70.27%
Selling, General & Admin $46.50M $52.61M $48.89M
YoY Change -5.01% 7.61% 28.11%
% of Gross Profit 95.06% 122.53% 121.8%
Research & Development $4.668M $5.410M $3.371M
YoY Change 20.81% 60.49% 19.37%
% of Gross Profit 9.54% 12.6% 8.4%
Depreciation & Amortization $891.0K $902.0K $902.0K
YoY Change 3.73% 0.0% 3.44%
% of Gross Profit 1.82% 2.1% 2.25%
Operating Expenses $51.17M $58.02M $52.26M
YoY Change -3.13% 11.02% 27.51%
Operating Profit -$2.252M -$15.08M -$12.12M
YoY Change -69.23% 24.45% -39.34%
Interest Expense $2.912M $2.510M $1.778M
YoY Change 33.15% 41.17% -26.8%
% of Operating Profit
Other Income/Expense, Net -$2.887M -$1.194M -$3.508M
YoY Change 25.14% -65.96% 41.51%
Pretax Income -$5.139M -$16.28M -$15.63M
YoY Change -46.61% 4.15% -30.41%
Income Tax $27.00K $35.00K $37.00K
% Of Pretax Income
Net Earnings -$5.166M -$16.31M -$15.67M
YoY Change -46.46% 4.13% -30.34%
Net Earnings / Revenue -7.49% -26.43% -27.43%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$49.67K -$0.16 -$173.3K
COMMON SHARES
Basic Shares Outstanding 106.1M 104.5M 92.01M
Diluted Shares Outstanding 104.5M

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.50M $46.90M $30.60M
YoY Change 102.5% 53.27% 30500.0%
Cash & Equivalents $40.75M $47.07M $30.66M
Short-Term Investments
Other Short-Term Assets $4.700M $5.400M $4.000M
YoY Change 46.88% 35.0% 1900.0%
Inventory $28.56M $26.44M $17.97M
Prepaid Expenses
Receivables $44.02M $32.72M $32.51M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $117.7M $111.4M $85.06M
YoY Change 54.58% 30.96% 28254.0%
LONG-TERM ASSETS
Property, Plant & Equipment $53.03M $50.07M $39.45M
YoY Change 30.14% 26.91%
Goodwill $25.54M $25.54M $25.54M
YoY Change 0.0% 0.0%
Intangibles $19.16M $19.98M $24.59M
YoY Change -19.63% -18.75%
Long-Term Investments
YoY Change
Other Assets $728.0K $760.0K $1.072M
YoY Change -30.0% -29.1% -99.66%
Total Long-Term Assets $98.78M $96.94M $91.39M
YoY Change 7.45% 6.07% -70.85%
TOTAL ASSETS
Total Short-Term Assets $117.7M $111.4M $85.06M
Total Long-Term Assets $98.78M $96.94M $91.39M
Total Assets $216.5M $208.3M $176.5M
YoY Change 28.8% 18.07% -43.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.94M $26.21M $24.58M
YoY Change 34.41% 6.64%
Accrued Expenses $24.69M $21.80M $20.40M
YoY Change 19.39% 6.9% 324.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $10.00M $4.900M $2.300M
YoY Change 316.67% 113.04%
Total Short-Term Liabilities $66.06M $54.83M $52.31M
YoY Change 31.07% 4.81% 925.63%
LONG-TERM LIABILITIES
Long-Term Debt $105.3M $105.1M $39.64M
YoY Change 165.49% 165.17%
Other Long-Term Liabilities $8.264M $6.966M $5.680M
YoY Change 32.86% 22.64% -47.89%
Total Long-Term Liabilities $8.264M $6.966M $45.32M
YoY Change -81.99% -84.63% 315.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.06M $54.83M $52.31M
Total Long-Term Liabilities $8.264M $6.966M $45.32M
Total Liabilities $180.7M $168.0M $143.9M
YoY Change 24.75% 16.78% 804.99%
SHAREHOLDERS EQUITY
Retained Earnings -$192.5M -$187.3M -$145.6M
YoY Change 24.01% 28.68%
Common Stock $228.2M $227.6M $178.1M
YoY Change 27.92% 27.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $728.5K $728.5K $728.5K
Shareholders Equity $35.75M $40.30M $32.56M
YoY Change
Total Liabilities & Shareholders Equity $216.5M $208.3M $176.5M
YoY Change 28.8% 18.07% -43.77%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$5.166M -$16.31M -$15.67M
YoY Change -46.46% 4.13% -30.34%
Depreciation, Depletion And Amortization $891.0K $902.0K $902.0K
YoY Change 3.73% 0.0% 3.44%
Cash From Operating Activities -$9.340M -$17.28M -$9.558M
YoY Change -22.87% 80.82% 114.45%
INVESTING ACTIVITIES
Capital Expenditures -$2.170M $4.243M $317.0K
YoY Change 83.9% 1238.49% 387.69%
Acquisitions
YoY Change
Other Investing Activities $290.0K
YoY Change
Cash From Investing Activities -$1.880M -$4.243M -$317.0K
YoY Change 59.32% 1238.49% 387.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.890M 8.230M 19.13M
YoY Change 74.64% -56.99% 520.8%
NET CHANGE
Cash From Operating Activities -9.340M -17.28M -9.558M
Cash From Investing Activities -1.880M -4.243M -317.0K
Cash From Financing Activities 4.890M 8.230M 19.13M
Net Change In Cash -6.330M -13.30M 9.258M
YoY Change -39.66% -243.62% -742.92%
FREE CASH FLOW
Cash From Operating Activities -$9.340M -$17.28M -$9.558M
Capital Expenditures -$2.170M $4.243M $317.0K
Free Cash Flow -$7.170M -$21.53M -$9.875M
YoY Change -34.4% 117.98% 118.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
21803000
CY2019Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
23450000
CY2020Q1 us-gaap Cash
Cash
46898000
CY2019Q4 us-gaap Cash
Cash
60174000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
111398000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
125600000
CY2020Q1 us-gaap Assets
Assets
208340000
CY2019Q4 us-gaap Assets
Assets
220687000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171007000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
40295000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54825000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55583000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
208340000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
59894000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220687000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15084000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12121000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
104486924
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1498000
CY2020Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
46000
CY2020Q1 us-gaap Liabilities
Liabilities
168045000
CY2019Q4 us-gaap Liabilities
Liabilities
165104000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
227604000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
226580000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-187320000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90604107
CY2020Q1 us-gaap Revenues
Revenues
61732000
CY2019Q1 us-gaap Revenues
Revenues
57123000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16313000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-15666000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
18793000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
16980000
CY2020Q1 us-gaap Gross Profit
GrossProfit
42939000
CY2019Q1 us-gaap Gross Profit
GrossProfit
40143000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52613000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48893000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5410000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3371000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
58023000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
52264000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2510000
CY2019Q1 us-gaap Interest Expense
InterestExpense
1778000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1194000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3508000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16278000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15629000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16313000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-15666000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
132000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
47041000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-816000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-209000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-224000
CY2019Q1 orgo Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
-628000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
32559000
CY2020Q1 us-gaap Depreciation
Depreciation
902000
CY2019Q1 us-gaap Depreciation
Depreciation
902000
CY2019Q4 us-gaap Inventory Net
InventoryNet
22918000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000
CY2019Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
115000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5164000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
217000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-76000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
209000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
224000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6325000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2474000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4287000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5076000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2099000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
963000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1910000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4882000
CY2020Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-1274000
CY2019Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
176000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-153000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-252000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17283000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9558000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4243000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
317000
CY2020Q1 orgo Non Cash Rent Expense Income
NonCashRentExpenseIncome
92000
CY2019Q1 orgo Non Cash Rent Expense Income
NonCashRentExpenseIncome
49000
CY2020Q1 orgo Deferred Interest Expense
DeferredInterestExpense
470000
CY2019Q1 orgo Deferred Interest Expense
DeferredInterestExpense
36000
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
176000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
196000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32724000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39359000
CY2020Q1 us-gaap Inventory Net
InventoryNet
26436000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2953000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50071000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47184000
CY2020Q1 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
576000
CY2019Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
556000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19981000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20797000
CY2020Q1 us-gaap Goodwill
Goodwill
25539000
CY2019Q4 us-gaap Goodwill
Goodwill
25539000
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
15000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
127000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
760000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
884000
CY2020Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3189000
CY2019Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3057000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
26208000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
28387000
CY2020Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
33484000
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
33484000
CY2020Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1105000
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1012000
CY2020Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
13755000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6966000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6649000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8230000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19133000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-187320000
CY2020Q1 orgo Working Capital
WorkingCapital
56573000
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
35928000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42408000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3204000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3049000
CY2019Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14431000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
11000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2020Q1 orgo Deferred Acquisition Consideration Liability Current
DeferredAcquisitionConsiderationLiabilityCurrent
1958000
CY2019Q4 orgo Deferred Acquisition Consideration Liability Current
DeferredAcquisitionConsiderationLiabilityCurrent
5000000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4243000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-317000
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4500000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13296000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9258000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60370000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21405000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30663000
CY2020Q1 us-gaap Interest Paid
InterestPaid
2244000
CY2019Q1 us-gaap Interest Paid
InterestPaid
1962000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
58000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
816000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
811000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3049000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3420000
CY2020Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-62000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3204000
CY2019Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-52000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3292000
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10142000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9178000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1622000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
781000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14672000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12959000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
728548
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7179636
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
95027
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.73
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6595480
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.66
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.93
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
9712000
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001661181
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 orgo Shares Reserved For Issuance For Future Option Grant
SharesReservedForIssuanceForFutureOptionGrant
8434696
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23450000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16463000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17640000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5340000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5810000
CY2020Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14928486
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15512642
CY2020Q1 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
5919490
CY2019Q4 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
6503646
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9712000
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
489129
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.67
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M3D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y29D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
144000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
266000
CY2019Q4 orgo Accrued Legal Expenses
AccruedLegalExpenses
542000
CY2020Q1 orgo Accrued Legal Expenses
AccruedLegalExpenses
1109000
CY2019Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
332000
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
10000000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
544000
CY2019Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
209000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2942000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
415000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16313000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17283000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37330000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17349000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19981000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37330000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16533000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20797000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21803000
CY2019Q4 orgo Shares Reserved For Issuance For Future Option Grant
SharesReservedForIssuanceForFutureOptionGrant
9008996
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5769399
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6457205
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1491000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
6234000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
16944000
CY2020Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3189000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1514000
CY2020Q1 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
43850000
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification of Prior Period Balances </div></div></div></div><div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification has been made to prior period amounts reported in the cash flows from operating activities section of the cash flow statement to conform to the current year presentation. The reclassification has no effect on the reported balance sheet as of December&#160;31, 2019, or net loss or equity or total operating, investing or financing cash flows for the period ended March&#160;31, 2019.&#160;</div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
769000
CY2019Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
257000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83694000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82774000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66713000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65812000
CY2019Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
49634000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
209000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
224000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106088563
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105599434
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105360015
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104870886
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1862000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2019Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
40000000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17585000
CY2019Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
6762000
CY2019Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
113000
CY2020Q1 orgo Payments Of Deferred Acquisition Consideration
PaymentsOfDeferredAcquisitionConsideration
2042000
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Trading Symbol
TradingSymbol
ORGO
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2020Q1 dei Security12b Title
Security12bTitle
Class&#160;A&#160;Common&#160;Stock,&#160;$0.0001&#160;par&#160;value
CY2020Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
1667000
CY2020Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
57910000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure as of the date of the consolidated financial statements and the reported results of operations during the reporting period. Actual results could differ from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
20000
CY2019Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
19000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1384000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
3594000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4786000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
4945000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
9853000
CY2020Q1 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
23178000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
4355000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5461000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2887000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2145000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1224000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6899000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22971000
CY2017 orgo Business Combinationdeferred Consideration Payment
BusinessCombinationdeferredConsiderationPayment
2500000
CY2019Q4 orgo Business Combination Deferred Consideration
BusinessCombinationDeferredConsideration
5000000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-201000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1862000
CY2019Q1 us-gaap Stock Issued1
StockIssued1
628000
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Organogenesis Holdings Inc.
CY2020Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
960000
CY2019Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
380000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
584300
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.04
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
10000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.04
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
574300
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.04
CY2020Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
4000000
CY2020Q1 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2000000
CY2020Q1 orgo Remaining Litigation Settlement Amount Payable
RemainingLitigationSettlementAmountPayable
2000000
CY2020Q1 orgo Remaining Litigation Settlement Amount Payable Per Quarter
RemainingLitigationSettlementAmountPayablePerQuarter
500000
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1295000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20799000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9712000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
16667000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20000000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
36817000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
93484000
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
106107921
CY2020Q1 orgo Gain Loss On Deferred Acquisition Consideration Settlement
GainLossOnDeferredAcquisitionConsiderationSettlement
1295000
CY2020Q1 orgo Gain Loss On Deferred Acquisition Consideration Settlement
GainLossOnDeferredAcquisitionConsiderationSettlement
1295000
CY2020Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-769000
CY2019Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-257000
CY2020Q1 orgo Shares Reserved For Issuance For Outstanding Restricted Stock Units
SharesReservedForIssuanceForOutstandingRestrictedStockUnits
574300
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7169780
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24938461
CY2019 orgo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Options Outstanding Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y21D
CY2020Q1 orgo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Options Outstanding Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y1M24D

Files In Submission

Name View Source Status
0001193125-20-139057-index-headers.html Edgar Link pending
0001193125-20-139057-index.html Edgar Link pending
0001193125-20-139057.txt Edgar Link pending
0001193125-20-139057-xbrl.zip Edgar Link pending
d915045d10q.htm Edgar Link pending
d915045dex104.htm Edgar Link pending
d915045dex311.htm Edgar Link pending
d915045dex312.htm Edgar Link pending
d915045dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orgo-20200331.xml Edgar Link completed
orgo-20200331.xsd Edgar Link pending
orgo-20200331_cal.xml Edgar Link unprocessable
orgo-20200331_def.xml Edgar Link unprocessable
orgo-20200331_lab.xml Edgar Link unprocessable
orgo-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending